Clinical Trial Update: Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 [Phase 2]

View source ↗

Summary

Phase 2 trial of ponsegromab in cancer patients with cachexia and elevated GDF-15 completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia
• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• Ponsegromab

Snippet

Sponsor: Pfizer | Conditions: Non-small Cell Lung Cancer, Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-04-29